BeOne Medicines (ONC)

BeOne Medicines (NASDAQ: ONC)

On December 17, 2025, BeOne Medicines Ltd. (the “Company”) appointed Dr. Lai Wang to serve as President, Global Head of Research and Development of the Company. In this role, Dr. Wang will oversee the research and development functions as well as other functions, including business development and alliance management.
Dr. Wang, age 48, has served as the Company’s Global Head of Research and Development since April 2021. Prior to that, he held various research and development leadership roles with increasing responsibilities since he joined the Company in 2011. Prior to joining the Company, Dr. Wang was Director of Research at Joyant Pharmaceuticals. Dr. Wang received a B.S. from Fudan University in 1996 and a Ph.D. from the University of Texas Health Science Center at San Antonio in 2001.

You May Also Be Interested In